Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-03 Purchase | 2023-08-07 5:13 pm | Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO | 83,857 | $23.96 | $2,008,811 | 83,857 (Indirect) | View |
| 2021-09-14 Sale | 2021-09-14 7:32 pm | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 954,053 | $38 | $36,254,014 | 0 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-10 Option Award | 2024-10-15 4:15 pm | N/A 2034-10-09 | Upstream Bio Inc. | UPB | Renaud Ronald C JR Director | 17,096 | $0 | 17,096 (Direct) | View |
Ownership | 2024-10-10 8:09 pm | N/A 2032-01-01 | Upstream Bio Inc. | UPB | Renaud Ronald C JR Director | 0 | $0 | 426,401 (Direct) | View |
| 2024-08-01 Disposition | 2024-08-05 4:36 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO | 1,064,823 | $0 | 0 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:31 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO | 284,023 | $0 | 284,023 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:18 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO | 160,452 | $0 | 244,309 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 4:53 pm | N/A 2033-06-12 | Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO | 536,572 | $0 | 536,572 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:48 pm | N/A 2032-06-22 | Atara Biotherapeutics Inc. | ATRA | Renaud Ronald C JR Director | 52,000 | $0 | 63,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 6:09 pm | N/A 2032-06-09 | Ikena Oncology Inc. | IKNA | Renaud Ronald C JR Director | 13,419 | $0 | 13,419 (Direct) | View |
| 2021-12-21 Option Award | 2021-12-23 6:35 pm | N/A 2031-12-21 | Ikena Oncology Inc. | IKNA | Renaud Ronald C JR Director | 13,419 | $0 | 13,419 (Direct) | View |
| 2021-04-07 Exercise(A) | 2021-09-14 7:31 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 9,026 | $7.39 | 2,025,062 (Direct) | View |
| 2021-04-07 Exercise(A) | 2021-09-14 7:31 pm | N/A 2027-12-21 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 9,026 | $0 | 2,025,062 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-09 7:13 pm | N/A 2031-06-07 | Atara Biotherapeutics Inc. | ATRA | Renaud Ronald C JR Director | 28,500 | $0 | 28,500 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 4:14 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 9,026 | $7.39 | 2,025,152 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 4:14 pm | N/A 2027-12-21 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 9,026 | $0 | 2,025,152 (Direct) | View |
Ownership | 2021-03-25 8:11 pm | N/A 2028-05-09 | Ikena Oncology Inc. | IKNA | Renaud Ronald C JR Director | 0 | $0 | 223,840 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-09 8:27 pm | N/A 2031-03-09 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 325,000 | $0 | 325,000 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-14 7:59 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 5,638 | $7.39 | 2,115,058 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-14 7:59 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 1 | $8.34 | 2,115,058 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-14 7:59 pm | N/A 2027-12-21 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 5,639 | $0 | 2,115,058 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:30 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 53,004 | $7.39 | 2,115,058 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:30 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 3 | $8.34 | 2,115,058 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:30 pm | N/A 2027-12-21 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 53,007 | $0 | 2,115,058 (Direct) | View |
| 2020-04-29 Option Award | 2020-04-30 7:44 pm | N/A 2030-04-28 | Atara Biotherapeutics Inc. | ATRA | Renaud Ronald C JR Director | 71,500 | $0 | 71,500 (Direct) | View |
| 2020-03-03 Option Award | 2020-03-05 7:53 pm | N/A 2030-03-02 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 525,000 | $0 | 525,000 (Direct) | View |